2m 2m 2m 2m 2m 2m 2m
LUNAI BIOWORKS (LNAI)
NASDAQ
$0.36-$0.16 (-31.47%)
Price as of Oct 22, 2026 7:59 PM EDT- $2.3MMarket Cap
- -93.52%1-Year Change
- BiotechnologyIndustry
LUNAI BIOWORKS (LNAI)
$0.36-$0.16 (-31.47%)
Annual
Quarterly
06/30/2026 | 06/30/2025 | 06/30/2024 | 06/30/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 51,992 N/A | N/A N/A | N/A N/A | -126,620 N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 51,992 N/A | 0 N/A | 0 +100.00% | -126,620 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | -537,428 -80.16% | -2.7M -34.97% | -4.2M -50.25% | |
Depreciation and Amortization Expense | 93,522 -27.56% | 129,095 +5.94% | 121,859 +7.37% | 113,496 -8.17% | |
Total Operating Expenses | 8.7M -95.37% | 189.0M +131.46% | 81.6M +111.74% | 38.6M -66.78% | |
Operating Profit | -8.7M -95.40% | -189.0M +131.46% | -81.6M +111.74% | -38.6M -66.78% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -6,316 -95.01% | -126,620 -66.04% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -6,316 -95.01% | -126,620 -49.51% | |
Total Nonoperating Income and Expense | 5.1M -53.14% | 11.0M +261.47% | -6.8M +502.09% | -1.1M -142.60% | |
Income before Taxes | -8.7M -95.40% | -189.0M +131.46% | -81.6M +105.72% | -39.7M -65.02% | |
Income Taxes | 1,406 -4.61% | 1,474 N/A | 0 N/A | N/A N/A | |
Extraordinary Items | 831,915 N/A | 0 N/A | 0 -100.00% | 19.0M -79.67% | |
Net Income | -3.6M -98.00% | -178.0M +101.31% | -88.4M +122.82% | -39.7M -65.02% | |
Net Income from Continuing Operations Applicable to Common | -3.6M -98.00% | -178.0M +101.31% | -88.4M +122.82% | -39.7M -65.02% | |
Basic EPS and Net Income | -1.06 -1.85% | -1.08 +18.68% | -0.91 +28.17% | -0.71 N/A | |
Diluted EPS and Net Income | -1.06 -1.85% | -1.08 +18.68% | -0.91 +28.17% | -0.71 N/A | |
Basic Weighted Average Shares | 3.4M -97.96% | 165.1M +69.27% | 97.5M +73.31% | 56.3M N/A | |
Diluted Weighted Average Shares | 3.4M -97.96% | 165.1M +69.27% | 97.5M +73.31% | 56.3M N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.7M +1,748.60% | 92,700 -57.95% | 220,467 -88.24% | 1.9M -79.56% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 1.7M +1,748.60% | 92,700 -57.95% | 220,467 -88.24% | 1.9M -79.56% | |
Total Current Assets | 2.0M +94.57% | 1.0M -47.61% | 2.0M -22.13% | 2.6M -73.18% | |
Accumulated Depreciation | 7,129 -98.98% | 702,180 +21.41% | 578,340 +24.43% | 464,799 +30.02% | |
Property and Plant and Equipment and Net | 12,015 -96.73% | 367,843 -23.70% | 482,121 -5.28% | 508,989 -13.22% | |
Total Long-Term Assets | 7.9M +15.80% | 6.8M -95.76% | 160.6M +190.89% | 55.2M -25.85% | |
Total Assets | 9.9M +20.79% | 8.2M -94.95% | 163.1M +179.81% | 58.3M -31.11% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 4.6M +285.41% | |
Total Current Liabilities | 18.9M -35.14% | 29.2M -3.81% | 30.3M +174.97% | 11.0M +70.88% | |
Total Long-Term Debt | 388,335 -89.85% | 3.8M +1,461.44% | 245,000 -79.58% | 1.2M -73.78% | |
Total Long-Term Liabilities | 56,248 -86.75% | 424,547 -49.60% | 842,389 +8.61% | 775,587 -86.06% | |
Total Liabilities | 19.0M -35.88% | 29.6M -5.04% | 31.2M +164.03% | 11.8M -1.79% | |
Retained Earnings | -514.0M +0.70% | -510.5M +53.54% | -332.5M +36.24% | -244.0M +19.42% | |
Total Stockholders Equity | N/A N/A | N/A N/A | 132.0M +183.81% | 46.5M -35.96% | |
Total Shares Outstanding | 4.6M -97.40% | 177.4M +11.95% | 158.5M +148.76% | 63.7M +20.17% | |
Cash Flow | |||||
Cash from Operating Activities | -5.3M -32.85% | -7.9M -28.23% | -11.0M -6.82% | -11.8M -25.16% | |
Capital Expenditures | 1,238 N/A | N/A N/A | 70,430 +136.55% | 29,774 +477.46% | |
Cash from Investing Activities | 543,462 +208.69% | -500,000 -60.32% | -1.3M +4,132.48% | -29,774 +477.46% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 6.4M -23.75% | 8.4M -20.30% | 10.5M +132.94% | 4.5M +6.23% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -16,729.37% N/A | N/A N/A | N/A N/A | 30,450.87% N/A | |
Return on Assets | -39.21% -81.13% | -207.76% +160.13% | -79.87% +43.83% | -55.53% -32.88% | |
Return on Equity | N/A N/A | N/A N/A | -99.09% +48.72% | -66.63% -27.38% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 0.11 +200.00% | 0.04 -45.52% | 0.07 -71.68% | 0.23 -84.31% | |
Cash Ratio | 0.09 +2,731.25% | 0.003 -56.16% | 0.007 -95.71% | 0.17 -88.04% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 0.13 +57.41% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.10 +46.27% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow